Trending/tolvaptan
Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment
ROCHESTER, Minn. – A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function…
No information found.
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community